Ms. Viboch plays a pivotal part in advancing General Catalyst’s life sciences investing practice. Since joining the company, she has helped invest $175 million in over 10 companies. Her investments support cutting edge technology platforms focused on developing novel medicines for critical patient use-cases. She also works with diagnostic companies, giving her unparalleled access into areas like radiology, pathology and liquid biopsy. These insights allow her to support the development of technology with clear decision-impact, clinical utility and medico-economic benefit to the healthcare system.
